Novo Nordisk (NVO) plans to start a late-stage clinical program next year to test oral and injectable forms of its new obesity therapy
https://seekingalpha.com/news/4457732-novo-to-begin-late-stage-trial-test-new-obesity-drug
Novo Nordisk (NVO) plans to start a late-stage clinical program next year to test oral and injectable forms of its new obesity therapy
https://seekingalpha.com/news/4457732-novo-to-begin-late-stage-trial-test-new-obesity-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.